Marcel de Matas

Formulation, SEDA Pharmaceutical Development Services Ltd. Formerly AstraZeneca

Marcel de Matas is the co-founder and Director of Seda Pharmaceutical Development Services, which is focussed on helping biotechnology and drug delivery companies to progress new medicinal products and technologies into clinical development and towards commercialisation.

During his 20-year career, Marcel has held a range of management and senior scientific positions in industry and academia. Most recently he was a Principal Scientist in Product Design and Innovation at AstraZeneca, where he was responsible for finding and implementing new science and technology in the Pharmaceutical Development group.

Marcel has provided project leadership and led product development teams responsible for the delivery of drug projects from initial concept design through late stage development and regulatory submission in readiness for launch. This has included a focus on enabling technologies for drug delivery. He has also led teams at the drug discovery-development interface, assessing the level of chemistry manufacturing and control (CMC) technical risk and defining product design strategies in early development. Project experience has covered molecules across a range of disease and therapy areas with substantial experience in the oncology field.